Rakon director appointment

ADMIN
Fri, Oct 24 2025 12:11 pm

Rakon Director Appointment
24 October 2025 – Rakon Limited (NZX: RAK), a world-leading manufacturer of precision timing and frequency control solutions, today announces in accordance with Listing Rule 3.20.1 the appointment of Christopher Swasbrook as a Non-Executive Director, effective from 28 October 2025.
The Board has determined in accordance with Listing Rule 2.6.2 that Mr Swasbrook will be an Independent Director.
Chair Lorraine Witten says: “We are pleased to welcome Chris as a Director of Rakon. His extensive resume, including more than 25 years’ experience in finance, as well as executive and governance roles across New Zealand businesses and organisations, is a valuable addition as we continue to rebuild the Board with a majority of Independent Directors.”
Mr Swasbrook has been a Board Member of the Financial Markets Authority (FMA) since 2019, having also served as a Member of the NZX Listing Subcommittee (2008-2023) and a Member of the New Zealand Markets Disciplinary Tribunal (2013-2023).
Mr Swasbrook holds a BCom (Econ) from the University of Auckland. He has also undertaken Executive Education courses at Columbia University (New York), New York University (NYU), London School of Economics (LSE) and the Harvard Kennedy School in Boston, Massachusetts.
Mr Swasbrook has been appointed by the Board in accordance with Rakon's Constitution and will put himself forward for election at the next Annual Meeting of the company.
Following Mr Swasbrook’s appointment, the Rakon Board comprises six directors, four of whom are Independent Directors.
ENDS
About Rakon
Rakon’s products help people to connect, explore and innovate. They are the ‘heartbeat’ for electronic systems, delivering fast, precise and stable timing in everything from mobile networks and autonomous vehicles to satellite constellations and AI data centres. Whether connecting to a 5G tower or to a rover exploring Mars, our technology is relied on to deliver the highest performance in even the most extreme conditions. Thanks to our constant drive to innovate, we continue to empower our customers to create the next generation of life-transforming technologies. For more information, visit www.rakon.com.
Contact
Investor and media relations
Nick Laurent
[email protected]
+64 21 240 7541


Announcement PDF


Markets News

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Rebecca Howard 24 Oct 2025
Fonterra windfall brings risks: ASB